Sponsored Content | Webinar | Proton Therapy| October 13, 2016

WEBINAR: Economics of Establishing a Proton Therapy Center

This webinar is sponsored by IBA

IBA, proton therapy, economics of proton therapy, ROI of proton therapy, Proteus One

The webinar "Economics of Establishing a Proton Therapy Center," will help educate hospitals and oncology centers about the economics of building a proton therapy center and how it can potentially expand oncology services. IBA will take the mystery out of establishing a proton therapy center by walking attendees through the cost, staff, ROI and reimbursement management for a proton therapy center.

The webinar takes place Thursday, Nov. 3, 2016, 2-3 p.m. Eastern Time

Register for this webinar

 

Speakers

Joy Godby, BA, ROCC
Associate Director for Radiation Oncology
University of Texas MD Anderson Cancer Center
Houston, Texas

Godby manages the entire revenue cycle for radiation oncology (billing, coding, patient access, financial counseling, upfront appeals and back end appeals for all modalities). Her talk "Managing the Maze of Insurance authorization for Radiation Therapy" includes insights to reimbursement for oncology services.

 

Robert McElearney MBA
Vice President Strategic Accounts
IBA Proton Therapy North America

McElearney’s background in healthcare spans almost 20 years, working in every part of the country in senior positions of leadership in the healthcare industry. He led business development for the nation’s largest provider of mobile imaging services, directing its effort to expand into new business areas. McElearney provides overall new business leadership for IBA Inc. in partnering with health facilitates in developing a Proton Therapy Center.

 

Mary Elizabeth (Beth) Klein,
President, IBA Proton Therapy North America

Klein joined IBA in 2009, after more than 25 years with GE Healthcare. There she held various leadership roles including leading the nuclear medicine business and was the Americas commercial executive at TomoTherapy 2005-2007.

 

About IBA

IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer.s. The company is the worldwide technology leader in the field of proton therapy, which is considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single-room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry.

Headquartered in Belgium and employing about 1300 people worldwide, IBA has installed systems across the world. IBA is listed on the Pan-European stock exchange NYSE EURONEXT. (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB) More information can be found at: www.iba-worldwide.com

 

Register for this webinar

Related Content

IBA Installs Three Proteus One Systems in One Week
News | Proton Therapy | April 28, 2017
April 28, 2017 — IBA announced the delivery and rigging of three Proteus One treatment rooms in less than a week at c
Nottingham City Hospital Selects RayStation for Radiotherapy Treatment Planning
News | Treatment Planning | April 28, 2017
Nottingham City Hospital in the United Kingdom has chosen RayStation as the new treatment planning system for its...
IBA Dosimetry Americas Announces New Exclusive Canadian Distributor for Radiotherapy Products
News | Radiation Therapy | April 28, 2017
April 28, 2017 — IBA (Ion Beam Applications S.A.) announced the Dosimetry Americas division has recently partnered wi
Early Stereotactic Radiosurgery Improves Outcomes for Nonfunctioning Pituitary Macroadenoma Patients
News | Radiation Therapy | April 27, 2017
Jason P. Sheehan, M.D., Ph.D., FAANS, winner of the Leksell Radiosurgery Award, presented his research on stereotactic...
Nine New Disease Sites Added to the NCCN Radiation Therapy Compendium
News | Radiation Therapy | April 26, 2017
April 26, 2017 — The National Comprehensive Cancer Network (NCCN) continues to build its NCCN Radiation Therapy Compe
Precision Medicine Poised to Change Brain Tumor Diagnostics and Treatment
News | Radiation Therapy | April 26, 2017
April 26, 2017 — A new report on the brain cancer diagnostics market projects that up to 78,000 new cases of primary
Elekta Highlights Leksell Vantage System for Stereotactic Neurosurgery at AANS 2017
News | Radiation Therapy | April 24, 2017
Elekta announced that its Leksell Vantage Stereotactic System, will be highlighted at the American Association of...
New Clinical Data on Xoft System Presented at American Brachytherapy Society Annual Meeting
News | Brachytherapy Systems, Women's Healthcare | April 20, 2017
iCAD Inc. announced that updated clinical data on the use of intraoperative radiation therapy (IORT) using the Xoft...
RaySearch and MD Anderson Collaborate on Development of RayCare
News | Oncology Information Management Systems (OIMS) | April 18, 2017
The University of Texas MD Anderson Cancer Center in Houston, Texas, will collaborate with RaySearch on the development...
New ASTRO Guideline Establishes Standard of Care for Curative Oropharyngeal Cancer Treatment With Radiotherapy
News | Radiation Therapy | April 17, 2017
April 17, 2017 — The American Society for Radiation Oncology (ASTRO) has issued a new clinical guideline for the mana
Overlay Init